The cardiovascular device industry in Europe plays a crucial role in advancing heart health through innovative medical technologies. It includes a broad range of companies that develop devices like stents, pacemakers, and diagnostic tools aimed at preventing and treating cardiac conditions. With rising cardiovascular diseases and an aging population, the sector is focused on enhancing treatment efficacy and patient quality of life. Future trends indicate a shift toward minimally invasive procedures and smart devices, integrating technology with healthcare to improve outcomes. Noteworthy advancements are expected as companies prioritize research and collaboration with healthcare providers.


This listing features 16 prominent investors within the cardiovascular device space in Europe. Investors vary widely, including venture capital firms, corporate investors, and private equity entities. These firms span diverse locations from London to Paris and Basel, with assets ranging from a handful to thousands of employees. Established between 1953 and 2006, collectively, they executed a significant number of 2024 investments—highlighting their robust interest in innovative health technologies.


Top 16 Cardiovascular Device Investors in Europe


1. European Innovation Council (EIC)


The European Innovation Council (EIC) is a public entity based in Brussels, Belgium, established to support innovation and entrepreneurship across Europe. Founded in 1958, the EIC offers various funding programs, including the EIC Accelerator and EIC Pathfinder, aimed at helping startups and SMEs develop and scale their technologies. In the context of cardiovascular devices, the EIC has been involved in significant transactions, such as providing blended funding of up to €17.5 million to CARMAT, which includes a non-dilutive grant and potential equity financing. Additionally, the EIC Fund participated in Corwave's funding rounds, including a €35 million Series C round. These transactions highlight the EIC's active role in financing innovative solutions in the cardiovascular device sector, alongside its broader mission to foster innovation across multiple industries.


2. Bpifrance French Tech Accélération


Bpifrance French Tech Accélération is a venture capital investor based in Paris, Île-De-France, France, founded in 2015. As a public entity and financial institution, Bpifrance supports entrepreneurs and businesses in France and internationally through a variety of services, including direct funding, export credit insurance, and private equity investments. They aim to foster entrepreneurship and innovation, helping businesses navigate growth and international expansion. Notably, Bpifrance has been involved in several significant transactions within the cardiovascular device sector. For instance, they participated in the Series B financing round for CorWave, a medical technology company focused on developing innovative solutions for heart failure, and in multiple funding rounds for LimFlow, which is advancing treatments for critical limb ischemia, a condition related to cardiovascular health. Their investments in these companies highlight their active role in the cardiovascular device industry.


3. Novo Holdings

  • Website: novoholdings.dk
  • Type: Venture Capital
  • Headquarters: Hellerup, Denmark
  • Founded year: 1999
  • Headcount: 51-200
  • Number of deals in 2024: 45
  • LinkedIn: novo-a-s

Novo Holdings A/S is a not-for-profit investment firm based in Hellerup, Denmark, founded in 1999. It manages the assets of the Novo Nordisk Foundation and invests in life science companies at various stages of development, providing capital and strategic support to enhance healthcare solutions. Notably, Novo Holdings has participated in several significant transactions within the cardiovascular device space, including investments in Preventice Solutions, which raised $137 million in a Series B financing round with participation from Novo Holdings, and iRhythm Technologies, which raised $17 million in a funding round led by Novo A/S. Additionally, they have invested in CorWave, a medical technology company, indicating their active role in supporting innovations in cardiovascular health.


4. Almi

  • Website: almi.se
  • Type: Venture Capital
  • Headquarters: Stockholm, Stockholm, Sweden
  • Founded year: 1994
  • Headcount: 201-500
  • Number of deals in 2024: 7
  • LinkedIn: almi-ab

Almi AB is a financial services company based in Stockholm, Sweden, founded in 1994. It specializes in providing loans, risk capital, and business development support to small and medium-sized enterprises (SMEs) in Sweden. Almi aims to enhance the growth and competitiveness of these businesses by offering tailored financial solutions and guidance. Among its notable transactions, Almi has invested in companies like Developeration, which manufactures surgical methods and devices, indicating a focus on healthcare innovation. Other investments include CathPrint, Sigrid Therapeutics, and Triomed AB, which, while not explicitly linked to cardiovascular devices, suggest a broader interest in health-related technologies. Almi's commitment to supporting SMEs in the healthcare sector positions it as a potential investor in cardiovascular device companies.


5. Sofinnova Partners


Sofinnova Partners is a venture capital firm based in Paris, Île-De-France, France, founded in 1972. The firm specializes in life sciences investments, focusing on innovative healthcare startups in the biopharma and medtech sectors. Sofinnova Partners has been involved in several significant transactions in the cardiovascular device space, particularly with Shockwave Medical, a company that develops treatments for peripheral and coronary vascular diseases. They participated in multiple funding rounds for Shockwave, including a $15 million Series D in December 2018, a $45 million Series C in November 2016, and a $40 million Series B in May 2015, which was aimed at developing Lithoplasty® balloon catheters for various vascular applications. This track record highlights their active role in advancing cardiovascular technologies and supporting startups that are innovating in this critical area of healthcare.


6. Agoranov

  • Website: agoranov.com
  • Type: Corporate
  • Headquarters: Paris, Île-De-France, France
  • Founded year: 2000
  • Headcount: 11-50
  • Number of deals in 2024: 42
  • LinkedIn: agoranov

Agoranov is a startup incubator based in Paris, Île-De-France, France, founded in 2000. The firm specializes in supporting early-stage technology and science startups by providing personalized assistance, fully equipped facilities, and acceleration programs. Among their notable investments, Agoranov has backed companies in the cardiovascular device sector, including Corwave, which raised funds in a seed round in June 2012, and Cardiawave, which also secured seed funding in May 2015. These investments highlight Agoranov's commitment to fostering innovation in cardiovascular health, alongside their broader focus on various innovative sectors.


7. Enterprise Ireland


Enterprise Ireland is a public entity that serves as the Irish government's enterprise development agency, founded in 1998. It supports Irish businesses at all stages of their growth journey by providing funding, advisory services, and market access assistance. The agency focuses on helping companies scale and compete internationally across various industries, including technology and manufacturing. Notably, Enterprise Ireland has been involved in several significant transactions within the cardiovascular device sector. For instance, they participated in funding rounds for CroíValve, which is developing minimally invasive treatments for tricuspid regurgitation, and Atrian Medical, which is working on a treatment for atrial fibrillation. Their investments in these companies demonstrate their engagement in the cardiovascular device industry, highlighting their role in fostering innovation and growth in this critical healthcare sector.


8. European Investment Bank (EIB)


The European Investment Bank (EIB), founded in 1958 and based in Luxembourg, is a public entity that provides a range of financial services including loans, equity investments, guarantees, and advisory services aimed at supporting sustainable projects across various sectors. In recent years, the EIB has made notable investments in the cardiovascular device industry, providing debt financing to companies such as CARMAT, which raised over $34 million, and Robocath, which secured approximately $17 million. Other significant transactions include Xeltis, Protembis, and Vivasure Medical, which collectively received substantial funding to advance their cardiovascular technologies. These investments highlight the EIB's role in fostering innovation and growth within the cardiovascular sector, aligning with its mission to promote projects that enhance health and well-being.


9. Novartis Venture Fund

  • Website: nvfund.com
  • Type: Venture Capital
  • Headquarters: Basel, Basel, Switzerland
  • Founded year: 1996
  • Headcount: 11-50
  • Number of deals in 2024: 10

Novartis Venture Fund is a venture capital firm based in Basel, Switzerland, specializing in life sciences investments. Founded in 1996, the fund focuses on providing funding and support to innovative biotechnology and biopharmaceutical companies, helping them develop novel therapeutics and address unmet patient needs. Notably, the fund has been involved in several transactions relevant to the cardiovascular device sector, including leading a $21.8 million Series C financing round for Ablation Frontiers, which is focused on investigational device trials for cardiovascular applications. Additionally, Novartis participated in funding rounds for Myopowers Medical Technologies, which is preparing for clinical trials related to cardiovascular devices. These transactions highlight the fund's commitment to advancing technologies that can significantly impact cardiovascular health.


10. Life Sciences Partners (LSP)

  • Website: lspvc.com
  • Type: Venture Capital
  • Headquarters: Amsterdam, North Holland, Netherlands
  • Founded year: 1987
  • Headcount: 11-50
  • Number of deals in 2024: 15
  • LinkedIn: lsp-bioventures

Life Sciences Partners (LSP) is a venture capital firm based in Amsterdam, Netherlands, founded in 1987. The firm specializes in private equity investments within the healthcare sector, connecting investors with innovative healthcare companies. LSP focuses on drug development and medical technology, aiming to foster advancements that address unmet medical needs. Among their notable transactions, LSP has invested in Cardiac Dimensions, participating in a $17.5 million Series C financing round in 2020 and a $15.2 million Series A round in 2015, both aimed at accelerating the commercial sales of the Carillon Mitral Contour System. Additionally, LSP has invested in BMEYE, which completed a €6M Series B financing round in 2009, further emphasizing their commitment to medical technology relevant to cardiovascular health.


11. Gilde Healthcare


Gilde Healthcare is a venture capital firm based in Utrecht, Netherlands, specializing in healthcare investments. Founded in 1982, the firm manages over €2.6 billion across two fund strategies: Venture & Growth and Private Equity. Gilde Healthcare focuses on innovative healthtech and therapeutics companies, as well as profitable lower mid-market healthcare providers in Europe. The firm has made significant investments in the cardiovascular device sector, including notable transactions such as a $50 million investment in CVRx, which specializes in cardiovascular therapies, and participation in multiple funding rounds for Ablative Solutions, a company developing renal denervation technology for hypertension treatment. These investments highlight Gilde Healthcare's strategic support for companies that are advancing cardiovascular health technologies.


12. HBM Healthcare Investments AG


HBM Healthcare Investments AG is a venture capital firm based in Zug, Switzerland, founded in 2001. The firm specializes in the healthcare sector, managing a diversified portfolio that includes investments in human medicine, biotechnology, medical technology, and diagnostics. In 2022, HBM Healthcare Investments participated in multiple funding rounds for Vascular Dynamics, a medical device company focused on cardiovascular solutions. Notably, they were involved in a $20 million equity financing round and several convertible note transactions, demonstrating their commitment to supporting innovations in the cardiovascular device market. This active engagement in relevant transactions highlights their role as a significant player in the healthcare investment landscape, particularly in the cardiovascular device sector.


13. Novartis

  • Website: novartis.com
  • Type: Corporate
  • Headquarters: Basel, Basel, Switzerland
  • Founded year: 1996
  • Headcount: 10001+
  • Number of deals in 2024: 7
  • LinkedIn: novartis

Novartis AG is a leading pharmaceutical company based in Basel, Switzerland, founded in 1996. The company specializes in developing and manufacturing innovative medicines aimed at addressing serious diseases across various therapeutic areas. Novartis emphasizes research and development to enhance patient outcomes globally. Notably, Novartis has participated in several significant transactions related to cardiovascular health, including a $192 million Series C funding round for Cleerly, a company focused on cardiovascular disease detection. Additionally, Novartis was involved in a $38 million Series D financing for Autonomic Technologies, which, while not exclusively cardiovascular, contributes to health technologies that may intersect with cardiovascular care. Their engagement in grants and funding for health tech initiatives further underscores their commitment to advancing healthcare solutions, including those in the cardiovascular domain.


14. Scottish Enterprise


Scottish Enterprise is a public entity established in 1991, dedicated to fostering economic development in Scotland. With a workforce of 1001-5000 employees, it provides a variety of services, including funding, business development advice, and support for innovation and exports. In 2024, Scottish Enterprise was involved in 55 investments, showcasing its active role in supporting businesses. Notably, it has participated in funding rounds for companies in the cardiovascular device sector, such as CardioPrecision, which focuses on innovative treatments for structural heart disease. Additionally, it has invested in Waire Health, a provider of remote patient monitoring devices, further emphasizing its engagement in health technology. These transactions highlight Scottish Enterprise's commitment to enhancing Scotland's economic landscape through strategic investments in the healthcare industry.


15. Abingworth

  • Website: abingworth.com
  • Type: Venture Capital
  • Headquarters: London, England, United Kingdom (UK)
  • Founded year: 1973
  • Headcount: 11-50
  • Number of deals in 2024: 6
  • LinkedIn: abingworth

Abingworth LLP is a London-based investment firm specializing in life sciences, founded in 1973. The firm focuses on providing capital and strategic support to biopharmaceutical companies, helping them develop innovative treatments. Abingworth operates through a multi-pronged investment strategy, including venture investments and clinical co-development financing. Notably, they have been involved in transactions such as Lombard Medical, which raised $41.5 million in post-IPO equity and focuses on vascular devices, indicating their interest in the cardiovascular device sector. Additionally, their investments in companies like Valeritas, which develops insulin delivery devices, showcase their broader engagement in medical technology, further supporting their relevance in the cardiovascular device space.


16. Andera Partners

  • Website: anderapartners.com
  • Type: Private Equity
  • Headquarters: Paris, Île-De-France, France
  • Founded year: 1953
  • Headcount: 51-200
  • Number of deals in 2024: 10
  • LinkedIn: anderapartners

Andera Partners is a private equity firm based in Paris, Île-De-France, France, founded in 1953. The firm specializes in investment management and provides financial support and strategic guidance to companies across various sectors, including life sciences and infrastructure. In recent years, Andera Partners has been actively involved in the cardiovascular device industry, participating in key funding rounds for companies such as BioVentrix, which is working on the Revivent TC System, and JenaValve Technology, which focuses on transcatheter aortic valve implantation systems. Their investments in these companies highlight their interest and expertise in the cardiovascular device market, as they support innovations aimed at improving cardiac health.



Cardiovascular Device Insights: Key Investors in Europe


InvestorHeadquarterSizeFoundedDeals 2024
European Innovation Council (EIC)Brussels, Brussels, Belgium201-500195857
Bpifrance French Tech AccélérationParis, Île-De-France, France1-102015198
Novo HoldingsHellerup, Denmark51-200199945
AlmiStockholm, Stockholm, Sweden201-50019947
Sofinnova PartnersParis, Île-De-France, France51-200197225
AgoranovParis, Île-De-France, France11-50200042
Enterprise IrelandDublin, Dublin, Ireland501-1000199848
European Investment Bank (EIB)Luxembourg1001-5000195899
Novartis Venture FundBasel, Basel, Switzerland11-50199610
Life Sciences Partners (LSP)Amsterdam, North Holland, Netherlands11-50198715
Gilde HealthcareUtrecht, Utrecht, Netherlands51-200198212
HBM Healthcare Investments AGZug, Zug, Switzerland1001-500020018
NovartisBasel, Basel, Switzerland10001+19967
Scottish EnterpriseGlasgow, Scotland, United Kingdom (UK)1001-5000199155
AbingworthLondon, England, United Kingdom (UK)11-5019736
Andera PartnersParis, Île-De-France, France51-200195310


Want to find more investors focusing on the cardiovascular device industry?

If you want to find more investors that are active in the cardiovascular deviceindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and there are a lot more private equity, venturecapital, and corporate investors like these globally.

With Inven, you'll also get to know:

  • Deal History: Number of deals and their sizes.
  • Portfolio: Companies they've invested in.
  • Contact data: Key dealmakers, including their emails and phonenumbers.
  • ...and much more!